Interview with Cesar Rengifo, President, GSK Brazil
You’ve made some bold moves in your career – from the head of vaccines in Latin America, followed by stints in Colombia, Puerto Rico, and finally Brazil. What brought you…
Founded on March 17, 2000, with headquarters in Lagoa da Prata, Minas Gerais, Pharlab is present throughout the country, and has been operating for 15 years for the development and well-being of the Brazilian population.
We produce medicines in the areas of semisolids – creams, ointments, lotions and gels, oral solids – tablets, coated tablets, powders for oral suspension, dragees, capsules and small volume injectables, with a portfolio active within the generics and hospital sectors.
In June 2012, Biogaran, a subsidiary of Servier Group, acquired 80% of Pharlab. This business marked Biogaran’s first investment in Brazil.
Contact:
Address: Rua Funchal, 418, Floor 34, Vila Olimpia, Sao Paolo, Brazil 04551-060
Tel.: +55 (11) 3521 7114
Website: www.pharlab.com.br
You’ve made some bold moves in your career – from the head of vaccines in Latin America, followed by stints in Colombia, Puerto Rico, and finally Brazil. What brought you…
We asked Mr. Santos regarding his recommendations to help the government innovate, compete, and grow in the pharmaceutical industry here in Brazil on the Human Genetic Therapies side. Is there…
Many international CROs entered Brazil in the past few years, whereas Quintiles made its first move in Brazil in 1996. What was the strategic decision behind entering Brazil at that…
PGS is a member of ABRACRO, but is in a unique position as both a CRO and a service provider to CROs and pharmaceutical companies. Can you elaborate on the…
The government recently released the ‘BrasilMaior’ plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow in the pharmaceutical industry…
The government recently released the BrasilMaior plan, whose slogan is “Innovate to compete. Compete to grow.” How would you recommend the government innovate, compete, and grow in the pharmaceutical industry…
We met recently with Minister Pimentel when he launched his BrasilMaior plan, whose slogan was “Innovate to Compete. Compete to Grow.” If you had to make a recommendation to increase…
When we last interviewed you in 2007, you said, “The generics business is a very exciting one,” but you “regret[ted] that the Government is not doing enough work to promote…
As I was doing research on your company, GC-2, I was unable to find a lot of information since it is a rather new company. Could you bring me up…
In a past interview, you said that Ipsen is different than the “Big Pharmas” who have entered Brazil by acquisition. You’ve taken a different tack since arriving as one of…
There is little publicly available information on your personal history and the founding of Meizler. Can you share that story for our readers? Everybody has a story – unless they’re…
An important topic in Brazil is access to drugs. In recent interviews we have spoken about a third of MS patients being treated, or 10% of hypertensives having their condition…
See our Cookie Privacy Policy Here
